Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,113.14
(
0.70%
)
US TECH 100
25,983.20
(
0.81%
)
Dow Jones
49,479.20
(
0.06%
)
Brent Oil
95.90
(
0.94%
)
Bitcoin
78,843.62
(
3.30%
)
News Focus
News Focus
Post# of 257435
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 118007

Sunday, 04/10/2011 3:06:24 PM

Sunday, April 10, 2011 3:06:24 PM

Post# of 257435

It’s an apples-to-oranges comparison



I completely agree. My point is that the "big picture" investment opportunity for the "median" oncology drug is at least as good as that for the median HCV drug. So the large number of oncology drugs in trials is not overly concerning for me.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today